<?xml version="1.0" encoding="UTF-8"?><meta xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns="http://www.w3.org/1999/xhtml" xmlns:xi="http://www.w3.org/2001/XInclude" http-equiv="Content-Type" content="text/html; charset=utf-8" />
<style xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns:xi="http://www.w3.org/2001/XInclude" type="text/css">
   @media screen{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .tds_obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:95%
   }
   .test-story-main table tbody tr td{
   font-size: 110%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   font-size:100%;
   }
   .test-story-main fieldset{
   text-align:center;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   
   }
   .test-story-main table th{
   border:2px groove;
   
   }
   .test-story-main table td{
   border:1px groove;
   
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:center;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .title{
   text-align:left;
   }
   .test-story-main h3{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .pgBrk{
   padding-top:15px;
   }
   .test-story-main .er7Msg{
   width:100%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
   
   @media print{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:90%
   }
   .test-story-main table tbody tr td{
   font-size:90%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   
   }
   .test-story-main table thead tr th{
   text-align:center;
   background:#4682B4;
   
   }
   .test-story-main fieldset{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   page-break-inside:avoid;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   }
   .test-story-main table th{
   border:2px groove;
   }
   .test-story-main table td{
   border:1px groove;
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:left;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left;
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .tds_title{
   text-align:left;
   margin-bottom:1%
   }
   .test-story-main h3{
   text-align:center;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .tds_pgBrk{
   page-break-after:always;
   }
   .test-story-main #er7Message table{
   border:0px;
   width:80%
   }
   .test-story-main #er7Message td{
   background:#B8B8B8;
   font-size:65%;
   margin-top:6.0pt;
   border:0px;
   text-wrap:preserve-breaks;
   white-space:pre;
   }
   .test-story-main .er7Msg{
   width:100%;
   font-size:80%;
   }
   .test-story-main .er7MsgNote{
   width:100%;
   font-style:italic;
   font-size:80%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .embSubSpace{
   padding-left:25px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
</style>
<!-- generated by TestStory_v1.xslt Version:1.0   Profile:TestStory-->
<fieldset>
<div class="test-story-main">
<tabset>
<tab heading="FULL"  vertical="false">
<div class="panel-body">

<div class="panel-body">
		<table>
		<tr>
		<th>Description</th>
		</tr>
		<tr>
		<td>After documenting vaccinations for Tyler Owen Banks the clinician, Lily Jackson (ID 456) recognizes that an error was made during data entry for the Hepatitis A vaccine. The Lot Number was entered incorrectly. She updates the data in the EHR and transmits it to the IIS.
		</td></tr>
		</table>
		<br/>
</div>


<div class="panel-body">
		<table>
		<tr>
		<th>Comments</th>
		</tr>
		<tr>
		<td>No Comments
		</td></tr>
		</table>
		<br/>
</div>


<div class="panel-body">
		<table>
		<tr>
		<th>Pre Condition</th>
		</tr>
		<tr>
		<td>The IZ-AD-5.1_Send_V04_Z22 test step has been successfully completed.<br>
		</td></tr>
		</table>
		<br/>
</div>


<div class="panel-body">
		<table>
		<tr>
		<th>Post Condition</th>
		</tr>
		<tr>
		<td>No PostCondition
		</td></tr>
		</table>
		<br/>
</div>


<div class="panel-body">
		<table>
		<tr>
		<th>Test Objectives</th>
		</tr>
		<tr>
		<td>Support for sending an update notification.<br>
		</td></tr>
		</table>
		<br/>
</div>


<div class="panel-body">
		<table>
		<tr>
		<th>Evaluation Criteria</th>
		</tr>
		<tr>
		<td>Message Validation Report. <div>Lot number that appears in RXA-15 in the message submitted for Test Case 5 will be changed in the message submitted for Test Case 6.<br><div><br></div></div>
		</td></tr>
		</table>
		<br/>
</div>


<div class="panel-body">
		<table>
		<tr>
		<th>Notes for Testers</th>
		</tr>
		<tr>
		<td>Lot number in test message changed from 208940 in Test Case 5 to 208490 in Test Case 6. <div>Since lot numbers cannot be pre-defined in the Test Data, the Test Suite does not automatically check for exact data in RXA-15; therefore, the Tester must manually verify that the lot number used in the test message for Test Case 5 was changed in the test message for Test Case 6. </div><div>For new administration messages, the vaccine is communicated using NDC codes in RXA-5 (Administered Code). For a given vaccine, one or more NDC codes may be appropriate to message. For this reason, RXA-5.1 is categorized as "Value - Test Case Fixed List" and allows for multiple valid values. The Message Content and Example Message data contain a single representative valid NDC code for example purposes. </div><div>ONC has determined that, from a regulatory/program perspective, an HIT Module cannot be required to be able to generate messages with the Vaccine Funding Source OBX segment for 2015 Edition certification testing. For certification purposes, ONC permits Testers to ignore the error notification generated by the NIST Immunization Test Suite when this segment is missing. Since the product under test will have to meet state reporting requirements when implemented, and many states require this information, it may be beneficial for HIT Modules to demonstrate support for the Vaccine Funding Source OBX segment during 2015 Edition certification testing. </div>
		</td></tr>
		</table>
		<br/>
</div>

</div>
</tab>
<tab heading="Description"  vertical="false">
<div class="panel-body">
		<table>
		<tr>
		<th>Description</th>
		</tr>
		<tr>
		<td>After documenting vaccinations for Tyler Owen Banks the clinician, Lily Jackson (ID 456) recognizes that an error was made during data entry for the Hepatitis A vaccine. The Lot Number was entered incorrectly. She updates the data in the EHR and transmits it to the IIS.
		</td></tr>
		</table>
		<br/>
</div>
</tab>
<tab heading="Comments"  vertical="false">
<div class="panel-body">
		<table>
		<tr>
		<th>Comments</th>
		</tr>
		<tr>
		<td>No Comments
		</td></tr>
		</table>
		<br/>
</div>
</tab>
<tab heading="Pre Condition"  vertical="false">
<div class="panel-body">
		<table>
		<tr>
		<th>Pre Condition</th>
		</tr>
		<tr>
		<td>The IZ-AD-5.1_Send_V04_Z22 test step has been successfully completed.<br>
		</td></tr>
		</table>
		<br/>
</div>
</tab>
<tab heading="Post Condition"  vertical="false">
<div class="panel-body">
		<table>
		<tr>
		<th>Post Condition</th>
		</tr>
		<tr>
		<td>No PostCondition
		</td></tr>
		</table>
		<br/>
</div>
</tab>
<tab heading="Test Objectives"  vertical="false">
<div class="panel-body">
		<table>
		<tr>
		<th>Test Objectives</th>
		</tr>
		<tr>
		<td>Support for sending an update notification.<br>
		</td></tr>
		</table>
		<br/>
</div>
</tab>
<tab heading="Evaluation Criteria"  vertical="false">
<div class="panel-body">
		<table>
		<tr>
		<th>Evaluation Criteria</th>
		</tr>
		<tr>
		<td>Message Validation Report. <div>Lot number that appears in RXA-15 in the message submitted for Test Case 5 will be changed in the message submitted for Test Case 6.<br><div><br></div></div>
		</td></tr>
		</table>
		<br/>
</div>
</tab>
<tab heading="Notes for Testers"  vertical="false">
<div class="panel-body">
		<table>
		<tr>
		<th>Notes for Testers</th>
		</tr>
		<tr>
		<td>Lot number in test message changed from 208940 in Test Case 5 to 208490 in Test Case 6. <div>Since lot numbers cannot be pre-defined in the Test Data, the Test Suite does not automatically check for exact data in RXA-15; therefore, the Tester must manually verify that the lot number used in the test message for Test Case 5 was changed in the test message for Test Case 6. </div><div>For new administration messages, the vaccine is communicated using NDC codes in RXA-5 (Administered Code). For a given vaccine, one or more NDC codes may be appropriate to message. For this reason, RXA-5.1 is categorized as "Value - Test Case Fixed List" and allows for multiple valid values. The Message Content and Example Message data contain a single representative valid NDC code for example purposes. </div><div>ONC has determined that, from a regulatory/program perspective, an HIT Module cannot be required to be able to generate messages with the Vaccine Funding Source OBX segment for 2015 Edition certification testing. For certification purposes, ONC permits Testers to ignore the error notification generated by the NIST Immunization Test Suite when this segment is missing. Since the product under test will have to meet state reporting requirements when implemented, and many states require this information, it may be beneficial for HIT Modules to demonstrate support for the Vaccine Funding Source OBX segment during 2015 Edition certification testing. </div>
		</td></tr>
		</table>
		<br/>
</div>
</tab>
</tabset>
		</div>
</fieldset>